Back to
JPMorgan Chase & Co.
ETON
8 quarters
Position history for
JPMorgan Chase & Co.'s holdings in Eton Pharmaceuticals, Inc.
Yes. JPMorgan Chase holds 191,635 shares of ETON (Eton Pharmaceuticals), worth $7M, as of its Q2 2026 13F filing. It increased the position by 21,759 shares (+12.8%) from Q1 2026. JPMorgan Chase has held ETON in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$7M
Current Shares
191,635
Total Value Change
+$7M
Total Shares Change
+190,912
Quarter-by-Quarter History
Other major holders of ETON: BlackRock, Inc., Vanguard Capital Management LLC